vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and Millrose Properties, Inc. (MRP). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $194.9M, roughly 1.7× Millrose Properties, Inc.). Millrose Properties, Inc. runs the higher net margin — 63.0% vs 4.0%, a 59.0% gap on every dollar of revenue. On growth, Millrose Properties, Inc. posted the faster year-over-year revenue change (135.7% vs 2.2%).
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
Millrose Properties, Inc. is a U.S.-based real estate enterprise primarily focused on the acquisition, ownership, operation, and management of income-generating multi-family residential assets. Its core markets span the U.S. Mid-Atlantic and Southeast regions, and it also offers professional property management services to select third-party property owners.
GRDN vs MRP — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $336.6M | $194.9M |
| Net Profit | $13.5M | $122.9M |
| Gross Margin | 22.7% | — |
| Operating Margin | 5.3% | 85.2% |
| Net Margin | 4.0% | 63.0% |
| Revenue YoY | 2.2% | 135.7% |
| Net Profit YoY | 46.1% | 208.7% |
| EPS (diluted) | $0.21 | $0.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.6M | $194.9M | ||
| Q4 25 | $397.6M | $189.5M | ||
| Q3 25 | $377.4M | $179.3M | ||
| Q2 25 | $344.3M | $149.0M | ||
| Q1 25 | $329.3M | $82.7M | ||
| Q3 24 | $314.4M | — |
| Q1 26 | $13.5M | $122.9M | ||
| Q4 25 | $20.9M | $122.2M | ||
| Q3 25 | $9.8M | $105.1M | ||
| Q2 25 | $9.0M | $112.8M | ||
| Q1 25 | $9.4M | $39.8M | ||
| Q3 24 | $-122.0M | — |
| Q1 26 | 22.7% | — | ||
| Q4 25 | 21.5% | — | ||
| Q3 25 | 19.8% | — | ||
| Q2 25 | 19.8% | — | ||
| Q1 25 | 19.5% | — | ||
| Q3 24 | 19.4% | — |
| Q1 26 | 5.3% | 85.2% | ||
| Q4 25 | 7.7% | 84.8% | ||
| Q3 25 | 4.3% | 85.3% | ||
| Q2 25 | 3.7% | 85.1% | ||
| Q1 25 | 3.9% | 55.2% | ||
| Q3 24 | -33.3% | — |
| Q1 26 | 4.0% | 63.0% | ||
| Q4 25 | 5.3% | 64.5% | ||
| Q3 25 | 2.6% | 58.6% | ||
| Q2 25 | 2.6% | 75.7% | ||
| Q1 25 | 2.9% | 48.1% | ||
| Q3 24 | -38.8% | — |
| Q1 26 | $0.21 | $0.74 | ||
| Q4 25 | — | $0.74 | ||
| Q3 25 | — | $0.63 | ||
| Q2 25 | — | $0.68 | ||
| Q1 25 | — | $0.39 | ||
| Q3 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $64.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $232.4M | $5.9B |
| Total Assets | $426.9M | $9.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $64.9M | — | ||
| Q4 25 | $65.6M | $35.0M | ||
| Q3 25 | $36.5M | $242.6M | ||
| Q2 25 | $18.8M | $66.6M | ||
| Q1 25 | $14.0M | $89.5M | ||
| Q3 24 | $37.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | $0 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $34.3M | — |
| Q1 26 | $232.4M | $5.9B | ||
| Q4 25 | $217.9M | $5.9B | ||
| Q3 25 | $195.5M | $5.9B | ||
| Q2 25 | $179.7M | $5.9B | ||
| Q1 25 | $163.2M | $5.9B | ||
| Q3 24 | $133.9M | — |
| Q1 26 | $426.9M | $9.6B | ||
| Q4 25 | $412.7M | $9.3B | ||
| Q3 25 | $390.0M | $9.0B | ||
| Q2 25 | $356.3M | $8.0B | ||
| Q1 25 | $334.0M | $7.2B | ||
| Q3 24 | $348.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | 0.26× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $6.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.45× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $6.1M | — | ||
| Q4 25 | $34.6M | $3.7B | ||
| Q3 25 | $28.2M | $123.1M | ||
| Q2 25 | $19.9M | $109.1M | ||
| Q1 25 | $17.6M | $21.3M | ||
| Q3 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $24.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
| Q1 26 | 0.45× | — | ||
| Q4 25 | 1.65× | 30.05× | ||
| Q3 25 | 2.87× | 1.17× | ||
| Q2 25 | 2.21× | 0.97× | ||
| Q1 25 | 1.86× | 0.53× | ||
| Q3 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRDN
Segment breakdown not available.
MRP
| Option fee revenues | $185.3M | 95% |
| Development loan income | $9.6M | 5% |